Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Impaired Cognitive Function after Perineuronal Net Degradation in the Medial Prefrontal Cortex.

Paylor JW, Wendlandt E, Freeman TS, Greba Q, Marks WN, Howland JG, Winship IR.

eNeuro. 2018 Dec 28;5(6). pii: ENEURO.0253-18.2018. doi: 10.1523/ENEURO.0253-18.2018. eCollection 2018 Nov-Dec.

2.

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.

Kelly KR, Espitia CM, Zhao W, Wendlandt E, Tricot G, Zhan F, Carew JS, Nawrocki ST.

Oncotarget. 2015 Dec 1;6(38):41275-89. doi: 10.18632/oncotarget.5753.

3.

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?

Franqui-Machin R, Wendlandt EB, Janz S, Zhan F, Tricot G.

Oncotarget. 2015 Dec 1;6(38):40496-506. doi: 10.18632/oncotarget.5800. Review.

4.

Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.

Yang Y, Shi J, Gu Z, Salama ME, Das S, Wendlandt E, Xu H, Huang J, Tao Y, Hao M, Franqui R, Levasseur D, Janz S, Tricot G, Zhan F.

Cancer Res. 2015 Feb 1;75(3):594-604. doi: 10.1158/0008-5472.CAN-14-2362. Epub 2015 Jan 14.

5.

Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.

Salem K, McCormick ML, Wendlandt E, Zhan F, Goel A.

Redox Biol. 2015;4:23-33. doi: 10.1016/j.redox.2014.11.002. Epub 2014 Nov 18.

6.

Nek2 is a novel regulator of B cell development and immunological response.

Gu Z, Zhou W, Huang J, Yang Y, Wendlandt E, Xu H, He X, Tricot G, Zhan F.

Biomed Res Int. 2014;2014:621082. doi: 10.1155/2014/621082. Epub 2014 Nov 17.

7.

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.

Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, Janz S, Tricot G, Zhan F.

Oncotarget. 2014 Dec 15;5(23):11986-97.

8.

Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.

Hao M, Zang M, Wendlandt E, Xu Y, An G, Gong D, Li F, Qi F, Zhang Y, Yang Y, Zhan F, Qiu L.

Int J Cancer. 2015 Apr 15;136(8):1835-44. doi: 10.1002/ijc.29199. Epub 2014 Sep 19.

9.

Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.

Salama ME, Du S, Efimova O, Heikal NM, Wendlandt E, Toydemir RM, South S, Perkins SL, Hussong JW, Zhan F.

Leuk Lymphoma. 2015 Feb;56(2):426-33. doi: 10.3109/10428194.2014.931951. Epub 2014 Aug 4.

10.

A subset of CD20(+) MM patients without the t(11;14) are associated with poor prognosis and a link to aberrant expression of Wnt signaling.

Liu J, Gu Z, Yang Y, Wendlandt E, Xu H.

Hematol Oncol. 2014 Dec;32(4):215-7. doi: 10.1002/hon.2120. Epub 2014 Jan 9. No abstract available.

11.

The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation.

Wendlandt EB, Graff JW, Gioannini TL, McCaffrey AP, Wilson ME.

Innate Immun. 2012 Dec;18(6):846-55. doi: 10.1177/1753425912443903. Epub 2012 Apr 20.

12.

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP.

Lab Invest. 2010 Dec;90(12):1727-36. doi: 10.1038/labinvest.2010.126. Epub 2010 Jul 12.

13.

MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling.

Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP.

Am J Physiol Gastrointest Liver Physiol. 2010 Apr;298(4):G535-41. doi: 10.1152/ajpgi.00338.2009. Epub 2010 Feb 18.

Supplemental Content

Loading ...
Support Center